Oxcarbazepine
Oxcarbazepine oral suspension is indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults and as monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years and above, and as adjunctive therapy in pediatric patients age…
United States
$15
per month
India
$1
per month
You save
−93%save $14/mo · 93% cheaper
1.3M US scripts/yr$18.5M potential annual savings$20M US spend/yr
Drag to rotate · 3D structureC15H12N2O2
SMILES: C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
Compare the price
US price$15per month
India price$2per month
You save$1489% less
Based on 30 units per month. US $0.52 vs India $0.06 per unit.
Total over 1 periodSave $14$15 → $2
The bigger picture
Oxcarbazepine is filled about 1.3M times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$20M
If sourced from India
$1.5M
Potential annual savings
$18.5M
−93%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.